December 17, 2009 (Ann Arbor, Michigan) — New laboratory research suggests that the COX-2 inhibitor celecoxib (Celebrex, Pfizer), might impede the action of "baby" aspirin [1]. Dr Gilad Rimon ...

Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

Phase I study of MRX-1024 in preventing oral mucositis (OM) in head and neck cancer patients undergoing chemoradiation therapy No significant financial relationships to disclose. This is an ASCO ...

Ornithine decarboxylase (Odc)-1 gene polymorphism effects on baseline tissue polyamine levels and adenoma recurrence in a randomized phase III adenoma prevention trial of DFMO + sulindac versus ...

In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the ...

NEW ORLEANS -- After 10 years during which 24,000 osteoarthritis (OA) and rheumatoid arthritis (RA) patients were randomized, the verdict on cardiovascular safety of NSAIDs is in and it's not all that ...

NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...

A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification—commonly called NSAIDs. Now, a big-data analysis of ...

Major depression is associated with a deficiency in serotonergic and noradrenergic neurotransmission. Although the cause of this deficiency is unclear, it is thought that an inflammatory process might ...

The pain pill celecoxib (Celebrex), along with two similar drugs, hit the US market in the late 1990s and early 2000s and quickly racked up billions of dollars in profit. But serious side effects led ...